SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-20-001832
Filing Date
2020-07-06
Accepted
2020-07-06 15:00:00
Documents
1
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 form4-07062020_110748.html 4  
1 form4-07062020_110748.xml 4 8367
  Complete submission text file 0001415889-20-001832.txt   9872
Mailing Address C/O AMPIO PHARMACEUTICALS, INC. 5445 DTC PARKWAY, SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address
MACALUSO MICHAEL (Reporting) CIK: 0001096423 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35182 | Film No.: 201013277

Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Issuer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations